{"id": "1360842571275198464", "creation": 1613285126.0, "user_id": "288344742", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 3, "reply_count": 0, "like_count": 4, "quote_count": 0}}, "text": "\"South Africa's #vaccine strategy calls for diversity of portfolio, country's also very optimistic about China's Sinopharm #COVID19 vaccine which is being tested against the 501Y.V2 variant.\" \nWatch full interview on #Africamatters \ud83d\udc47https://t.co/k8gExAAKaT https://t.co/rVTFcafkgW", "first_save": 1634559108.199414, "hashtags": ["#VACCINE", "#COVID19", "#AFRICAMATTERS"]}